8-K: Damon Inc. Announces $15 Million Unit Offering and Nasdaq Compliance Plan

Damon Inc. completed a $15 million unit offering and is addressing a Nasdaq listing deficiency.

Summary

• Damon Inc. has entered into an underwriting agreement with Maxim Group LLC for a unit offering.
• The offering consists of 126.9 million units at $0.13 per unit, each containing one common share and one Series A warrant.
• The company also granted the underwriter warrants to purchase 6.345 million common shares.
• The Series A warrants have an initial exercise price of $0.195 per share and expire in 2.5 years.
• The warrants include a cashless exercise option and price reset mechanisms on the 7th and 15th trading days after issuance, with a floor price of $0.0251.
• The underwriter exercised its over-allotment option for 19,035,000 Series A warrants.
• Maxim Group LLC received 6.5% of the gross proceeds as underwriting discounts and commissions, plus up to $100,000 for out-of-pocket expenses.
• The offering closed on March 21, 2025, with net proceeds of approximately $15 million.
• The company intends to use the proceeds for working capital, R&D, marketing, and repaying 14% of a secured promissory note to Streeterville Capital, LLC.
• Damon Inc. received a Nasdaq notice regarding its Market Value of Publicly Held Shares (MVPHS) falling below $15 million.
• The company has until September 16, 2025, to regain compliance.
• The company may consider transferring its listing to The Nasdaq Capital Market.
• Damon Inc. amended its agreement with Mark Peikin, a former financial advisor, agreeing to pay $2,515,000, with $1,000,000 potentially paid in common shares.
• Peikin surrendered 1,255,230 common shares previously issued to him.
• East West Capital's note purchase agreement was terminated.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company successfully raised capital, it also faces challenges with Nasdaq compliance and potential dilution from warrant exercises. The capital raise is a positive, but the Nasdaq notice and warrant terms introduce uncertainty.

Positives

• The $15 million capital injection will be used for working capital, R&D, and marketing.
• The company is taking steps to address the Nasdaq listing deficiency.
• The company terminated the East West Capital note purchase agreement.

Negatives

• The company received a Nasdaq notice for failing to maintain a minimum MVPHS of $15 million.
• The company will likely not receive any additional funds upon the exercise of the Series A Warrants.
• The Series A Warrants exercise price will be reset twice, potentially diluting existing shareholders.

Risks

• The company's ability to regain compliance with Nasdaq listing requirements is uncertain.
• The company may not receive additional funds from the exercise of Series A warrants due to the cashless exercise option.
• The reset of the Series A warrant exercise price could lead to further dilution.
• The company's reliance on future equity financing may be impacted by the lock-up agreement with Peikin.

Future Outlook

The company intends to use the net proceeds for working capital, research and development, marketing and sales, and repaying a portion of a secured promissory note.

Industry Context

The announcement reflects a common strategy for companies seeking capital to fund operations and growth, while also addressing regulatory compliance issues related to stock exchange listing requirements. The use of unit offerings with warrants is a structure often employed by smaller companies.

Comparison to Industry Standards

• Comparable companies in similar situations often pursue strategies such as reverse stock splits, seeking alternative financing, or transferring to a different exchange to maintain their listing.
• The terms of the warrants, including the reset provisions, are structured to incentivize early exercise but also provide downside protection, which is a common feature in offerings by companies with volatile stock prices.
• The underwriting fee of 6.5% is within the typical range for similar-sized offerings, although it can vary based on market conditions and the complexity of the deal.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares and potential warrant exercises.
• Employees may benefit from the company's increased financial stability and ability to invest in R&D and marketing.
• Creditors will see a portion of the company's debt repaid.
• Customers may benefit from improved products and services resulting from increased R&D and marketing efforts.

Next Steps

• The company intends to monitor the closing price of its Common Shares and evaluate options to resolve the MVPHS deficiency.
• The company may consider applying to transfer the listing of its securities to The Nasdaq Capital Market.
• The company will file a resale registration statement covering the shares to be issued to Peikin.
• The company will file reports with the Commission regarding the sale of the Offered Securities and the application of the proceeds.

Key Dates

Keywords

offering, warrants, compliance, MVPHS, Nasdaq, underwriting, shares, Damon